Trials / Unknown
UnknownNCT03062033
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- Neurocrine Biosciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective study to quantify the prevalence of possible tardive dyskinesia (TD) in outpatient psychiatry practices in the United States (US), as well as to describe the associated disease burden in a cohort of patients with one or more psychiatric disorders and a cumulative lifetime exposure to antipsychotic medication of three months or more.
Conditions
Timeline
- Start date
- 2017-04-04
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2017-02-23
- Last updated
- 2017-11-22
Locations
34 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03062033. Inclusion in this directory is not an endorsement.